Neil King

Seattle, Washington, USA

Trump-Era Funding Cuts and Hiring Freeze Stall UW Protein Design Startups Led by Nobel Laureate David Baker

The University of Washington's Institute for Protein Design, led by Nobel laureate David Baker, faces a hiring freeze and funding cuts under the Trump administration, stalling its promising protein design startups and reducing opportunities for graduate students and postdocs. Despite Nobel-driven interest and advances in AI-designed proteins, budget constraints threaten future innovation and company spinoffs.

AstraZeneca to Acquire UW Spinout Icosavax for Up to $1.1 Billion to Boost Respiratory Vaccine Development

AstraZeneca announced it will acquire Seattle-based biotech spinout Icosavax, founded at the University of Washington, for up to $1.1 billion to accelerate development of vaccines targeting respiratory viruses. Icosavax's shares surged over 40% after the deal, which values the company at a 43% premium and aims to advance its lead RSV and hMPV vaccine candidate.

See all 11 news stories about Neil King.

Organizations